Literature DB >> 35992531

Practical management of esophageal varices in the context of SARS-CoV-2 (COVID-19): the Alberta protocol.

Stephen E Congly1, Matthew D Sadler1, Juan G Abraldes2, Puneeta Tandon2, Samuel S Lee1, Kelly W Burak1.   

Abstract

The challenges of managing varices during the COVID-19 pandemic are reviewed, and a treatment algorithm is presented to best manage patients with advanced liver disease during periods of limited access to endoscopy.
Copyright © 2020 Canadian Association for the Study of the Liver.

Entities:  

Keywords:  carvedilol; nadolol; pandemic; portal hypertension

Year:  2020        PMID： 35992531      PMCID： PMC9202704          DOI： 10.3138/canlivj-2020-0007

Source DB:  PubMed          Journal:  Can Liver J        ISSN： 2561-4444


  8 in total

Review 1.  Current management of portal hypertension.

Authors:  Jaime Bosch; Juan G Abraldes; Roberto Groszmann
Journal:  J Hepatol       Date:  2003       Impact factor: 25.083

2.  Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.

Authors:  Guadalupe Garcia-Tsao; Juan G Abraldes; Annalisa Berzigotti; Jaime Bosch
Journal:  Hepatology       Date:  2016-12-01       Impact factor: 17.425

3.  Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The "Anticipate" study.

Authors:  Juan G Abraldes; Christophe Bureau; Horia Stefanescu; Salvador Augustin; Michael Ney; Hélène Blasco; Bogdan Procopet; Jaime Bosch; Joan Genesca; Annalisa Berzigotti
Journal:  Hepatology       Date:  2016-10-27       Impact factor: 17.425

4.  Endoscopic screening for varices in cirrhotic patients: data from a national endoscopic database.

Authors:  Mary Kovalak; Jeremy Lake; Nora Mattek; Glenn Eisen; David Lieberman; Atif Zaman
Journal:  Gastrointest Endosc       Date:  2007-01       Impact factor: 9.427

5.  Stratifying risk in the prevention of recurrent variceal hemorrhage: Results of an individual patient meta-analysis.

Authors:  Agustín Albillos; Javier Zamora; Javier Martínez; David Arroyo; Irfan Ahmad; Joaquin De-la-Peña; Juan-Carlos Garcia-Pagán; Gin-Ho Lo; Shiv Sarin; Barjesh Sharma; Juan G Abraldes; Jaime Bosch; Guadalupe Garcia-Tsao
Journal:  Hepatology       Date:  2017-08-26       Impact factor: 17.425

6.  Gastrointestinal endoscopy during the COVID-19 pandemic: an updated review of guidelines and statements from international and national societies.

Authors:  Elio C Castro Filho; Rodolfo Castro; Flavia F Fernandes; Gustavo Pereira; Hugo Perazzo
Journal:  Gastrointest Endosc       Date:  2020-04-05       Impact factor: 9.427

7.  COVID-19: Advice from the Canadian Association of Gastroenterology for Endoscopy Facilities, as of March 16, 2020.

Authors:  Frances Tse; Mark Borgaonkar; Grigorios I Leontiadis
Journal:  J Can Assoc Gastroenterol       Date:  2020-03-27

8.  Coronavirus (COVID-19) outbreak: what the department of endoscopy should know.

Authors:  Alessandro Repici; Roberta Maselli; Matteo Colombo; Roberto Gabbiadini; Marco Spadaccini; Andrea Anderloni; Silvia Carrara; Alessandro Fugazza; Milena Di Leo; Piera Alessia Galtieri; Gaia Pellegatta; Elisa Chiara Ferrara; Elena Azzolini; Michele Lagioia
Journal:  Gastrointest Endosc       Date:  2020-03-14       Impact factor: 9.427
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.